Delivery Order SPE2DB22D1106-SPE2DB25FEUX1
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of REFRESH PLUS 0.5% EYE DROPS 30S, with a ceiling value of $2,827.68 and a performance period ending on June 30, 2025. The contract is not set aside and was awarded on an open competition basis. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product, with a ceiling value of $3,388.44 and a period of performance through May 16, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, which has a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product, with a firm fixed price ceiling value of $1,297.80 and a period of performance through June 16, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S", a pharmaceutical product, with a ceiling value of $1,867.19 and a completion date of May 2, 2024. The contract is a firm-fixed price type and does not have a set-aside designation, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a medical product, with a ceiling value of $1,458.72 and a completion date of July 3, 2025. The contract is a firm fixed-price delivery order, which means Amerisourcebergen will provide the specified product at a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product, with a ceiling value of $2,413.19 and a period of performance through March 12, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp also holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,420.80 firm-fixed-price contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical. This IDC, designated as SPE2DX, provides a...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Refresh Plus 0.5% eye drops, with a ceiling value of $1,656.53 and a period of performance through June 13, 2025. This delivery order is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product, with a ceiling value of $3,762.10. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S." The contract has a ceiling value of $3,097.72 and a period of performance through July 19, 2024. The contract is a firm-fixed-price, non-set-aside award. Amerisourcebergen, through its Corporate Office division, is responsible for delivering the requested eye drops to support federal...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEUX1Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product, with a ceiling value of $4,704.46 and a period of performance extending through June 25, 2025. The contract is not set aside and was awarded on a competitive, non-set-aside basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This award appears to be a delivery order placed against that larger IDC contract, enabling Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 6/24/25 |